Willow Biosciences Statistics
Total Valuation
CANSF has a market cap or net worth of 3.76 million. The enterprise value is 4.12 million.
| Market Cap | 3.76M |
| Enterprise Value | 4.12M |
Important Dates
The next estimated earnings date is Monday, August 11, 2025.
| Earnings Date | Aug 11, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 147.20M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +11.81% |
| Shares Change (QoQ) | +1.77% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 114.67M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.85 |
| PB Ratio | -7.84 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -1.43 |
| EV / Sales | 0.89 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -2.91 |
Financial Position
The company has a current ratio of 1.01
| Current Ratio | 1.01 |
| Quick Ratio | 0.11 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.37 |
| Interest Coverage | -11.39 |
Financial Efficiency
Return on equity (ROE) is -971.43% and return on invested capital (ROIC) is -116.15%.
| Return on Equity (ROE) | -971.43% |
| Return on Assets (ROA) | -61.18% |
| Return on Invested Capital (ROIC) | -116.15% |
| Return on Capital Employed (ROCE) | -9,914.97% |
| Revenue Per Employee | 233,251 |
| Profits Per Employee | -151,888 |
| Employee Count | 19 |
| Asset Turnover | 1.85 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -70.80% in the last 52 weeks. The beta is 1.40, so CANSF's price volatility has been higher than the market average.
| Beta (5Y) | 1.40 |
| 52-Week Price Change | -70.80% |
| 50-Day Moving Average | 0.01 |
| 200-Day Moving Average | 0.04 |
| Relative Strength Index (RSI) | 57.16 |
| Average Volume (20 Days) | 110,066 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, CANSF had revenue of 4.43 million and -2.89 million in losses. Loss per share was -0.02.
| Revenue | 4.43M |
| Gross Profit | 912,095 |
| Operating Income | -2.35M |
| Pretax Income | -2.89M |
| Net Income | -2.89M |
| EBITDA | -2.03M |
| EBIT | -2.35M |
| Loss Per Share | -0.02 |
Balance Sheet
The company has 176,714 in cash and 516,228 in debt, giving a net cash position of -339,514.
| Cash & Cash Equivalents | 176,714 |
| Total Debt | 516,228 |
| Net Cash | -339,514 |
| Net Cash Per Share | n/a |
| Equity (Book Value) | -480,050 |
| Book Value Per Share | -0.00 |
| Working Capital | 11,827 |
Cash Flow
In the last 12 months, operating cash flow was -1.40 million and capital expenditures -13,914, giving a free cash flow of -1.41 million.
| Operating Cash Flow | -1.40M |
| Capital Expenditures | -13,914 |
| Free Cash Flow | -1.41M |
| FCF Per Share | n/a |
Margins
Gross margin is 20.58%, with operating and profit margins of -52.92% and -65.12%.
| Gross Margin | 20.58% |
| Operating Margin | -52.92% |
| Pretax Margin | -65.10% |
| Profit Margin | -65.12% |
| EBITDA Margin | -45.84% |
| EBIT Margin | -52.92% |
| FCF Margin | n/a |
Dividends & Yields
CANSF does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -11.81% |
| Shareholder Yield | n/a |
| Earnings Yield | -76.67% |
| FCF Yield | -37.56% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on May 21, 2019. It was a reverse split with a ratio of 0.04.
| Last Split Date | May 21, 2019 |
| Split Type | Reverse |
| Split Ratio | 0.04 |
Scores
CANSF has an Altman Z-Score of -77.45. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -77.45 |
| Piotroski F-Score | n/a |